Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

drug_safety

Drug safety: UK and EU post-Brexit

September 10, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, EU, Europe, MHRA, UK, brexit, drug safety, pharmacovigilance

What does Brexit mean for drug safety in Europe and the United Kingdom? Louis Goss looks into Britain’s exit from …
Feature
nhs_sign

UK Government to invest £200m in IT and technology boost for NHS

September 7, 2018 Medical Communications, Sales and Marketing AI, Matt Hancock, NHS, NHS expo, pharma

The UK Government has lifted the curtain on plans invest more than £200 million to leverage innovations in technology and …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

September 7, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, MHRA, Trump, brexit, research, scandal, top 10

Brexit took the top two spots this week after it was revealed that the EMA has awarded Britain’s MHRA just …
News
canadian-flag-1229484_960_720

BC Liberal criticises opioid lawsuit for focusing too heavily on drugmakers

September 7, 2018 Medical Communications

The British Columbia Liberal opposition Critic for Mental Health and Addictions has tweeted that the lawsuits seeking damages from pharmaceutical …
News
gilead-sciences

Gilead and Galapagos’ ankylosing spondylitis drug hits Phase 2 trial goal

September 7, 2018 Medical Communications, Research and Development Galapagos, Gilead, ankylosing spondylitis, filgotinib, pharma

Gilead and Galapagos have announced that their jointly-developed selective JAK1 inhibitor filgotinib has met its primary endpoint in a Phase …
News
5204602349_c87b204860_z

FDA recruitment official says Trump’s policies are making hiring difficult

September 7, 2018 Medical Communications FDA, Trump, US, hiring, recruitment

Melanie Keller, Acting Associate Commissioner for Scientific and Clinical Recruitment at the US Food and Drug Administration (FDA) has said …
News
sanjay_keswani

Rheos Medicines appoints Roche Senior Vice President and R&D head as new CEO

September 6, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, CEO, Roche, cembridge, massachussets, rheos, sanjay keswani

The Cambridge Massachusetts-based biopharmaceutical company Rheos Medicines has appointed former Roche Senior Vice President and Global R&D Head, Dr Sanjay …
Appointment
pshezhetskiy

A rational new approach to cancer treatment

September 6, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, University of East Anglia, feature, pharma

Researchers at the University of East Anglia have developed a new targeted cancer therapy which utilises nanoparticles to deliver treatment …
Feature
teva_canada_1

Teva drops MS and Huntington’s disease drug laquinimod, leaving rights to Active Biotech

September 6, 2018 Medical Communications, Research and Development Active Biotech, Laquinimod, Teva, pharma

Israeli multinational Teva Pharmaceutical has decided to discontinue the development of laquinimod. As such, all rights for the orally administered …
News
24327909026_6435de0904_z

Ketamine’s antidepressant effects may be linked to brain’s opioid system

September 6, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ketamine, antidepressant, depression, mental health, opioid

Ketamine’s antidepressant effect works through the activation of the brains opioid receptors, a new study published in The American Journal …
News
jackie_fouse_hires

Agios appoints Celgene’s Jacqualyn Fouse as new CEO

September 5, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, COO, Celgene, Jacqualyn Fouse, agios

The Massachusetts-based oncology specialist Agios Pharmaceuticals has appointed former Celgene President and COO Jacqualyn Fouse as their new Chief Executive …
Appointment
shutterstock_206748499

FDA turns to real-world evidence to improve regulatory process

September 5, 2018 Medical Communications, Research and Development, Sales and Marketing FDA, pharma, real world data, real world evidence, real-world data, real-world evidence

The FDA has announced its intention to incorporate real-world data elements to a greater degree into its regulatory decision-making framework …
News
melanie_lee_770x510

UK research charity LifeArc appoints experienced leader Melanie Lee as new CEO

September 4, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, melanie lee

The life sciences medical research charity LifeArc, formerly MRC Technology, has appointed Dr Melanie Lee as its new Chief Executive …
Appointment

Value, Access, and Regulatory Strategy Conference

September 4, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Conference, London, Regulatory Strategy, access, dia

News
Press release
dia_logo

DIA Value, Access, and Regulatory Conference 2018

September 4, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing dia, event, pharma

Dr Solange Corriol-Rohou, Senior Director, Global Regulatory Affairs & Policy, Europe, at AstraZeneca Global Medicines Development, discusses DIA’s upcoming Value, …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025